Laboratorio IVI Sevilla
14 November 2019
IVI Sevilla has enabled the birth of a baby who has succeeded in curing his sister’s rare disease

This is the first case in the world involving HLA-compatible pre-embryo biopsy at blastocyst stage to cure Diamond-Blackfan anaemia, and the first in Spain for any disease. Up to now, all cases had involved biopsy at day 3 of pre-embryo development and not after 5-6 days, when the chances of implantation and pregnancy are much… View Article

19 October 2019
Susana: “I held on to the wild card of preservation for a chance of motherhood in the future”

Susana, Irene and Estrella, three brave women who have won the battle against breast cancer. The desire to become mothers in the future gave them the strength to beat their illness. IVI launched its free “Becoming a Mother after Cancer” Programme in 2007. Since then, more than 800 women diagnosed with breast cancer have vitrified… View Article

16 October 2019
Women and couples with 3 normal embryos have a 95% chance of becoming pregnant

Genetic tests prior to implantation such as PGT-A allow abnormal embryos to be identified with precision without affecting implantation rates when biopsies are performed. The PGT-A test has enabled multiple pregnancies to be reduced and, as a result, has evened up birth weights between babies born through IVF and those conceived naturally. IVI presents an… View Article

1 October 2019
IVI reduces twin birth by 75% in the last decade

This type of pregnancies is associated with significant risks for both the mother and the newborn. According to the data published by SEF (Spanish Fertility Society), double embryo transfer numbers dropped from 82% in 2012 to 56% in 2016. The Belgian model in public health care shows a positive impact of the implemented policies, with… View Article

11 September 2019
Treatments with donated embryos triple in the last decade

Women who decide to face maternity alone with both donated gametes constitute 37% of all patients choosing embryo donation VALENCIA, 11 OF SEPTEMBER 2019 Embryo donation makes the dream of becoming parents true for women and couples who cannot become pregnant with their own gametes. In the last decade only, fertility treatments involving donated embryos… View Article

12 August 2019
A study by IVI Sevilla in collaboration with the IIQ (CSIC) yields new data on the possible causes of polycystic ovary syndrome

These findings allow a deeper understanding of the causes of polycystic ovary syndrome and could lead to the development of new treatments. This disease affects around 5-15% of women of reproductive age and is one of the most common causes of infertility. IVI Sevilla, together with the Instituto de Investigaciones Químicas (the Institute of Chemical… View Article

11 July 2019
Perfect Match 360°: Artificial intelligence and big data to match the perfect donor

This innovative IVI system takes into account phenotype, genetic and biometric criteria to ensure optimal donor allocation. Between 2014 and 2018, IVI clinics in Spain carried out more than 30,000 cycles of assisted reproduction with egg donation and almost 10,000 with donated semen, representing 28% and 9% respectively of the total cycles. IVI offers its… View Article

25 June 2019
A low progesterone level in the blood may reduce the chances of having a baby by 18%

The study, which included a group of almost 1.200 patients, aroused great interest among the scientific circles IVI presents a total of 49 communications: 14 oral, 31 posters y 4 invited sessions. VIENNA, 25 JUNE 2019 The importance of progesterone during pregnancy and even for facilitating the implantation of the embryo prior to getting pregnant… View Article

PRESS ROOM CONTACTS

  • Ricardo Pedrós
  • Lucía Renau
  • Email: prensa@ivi.es
  • Phone number: (0034) 96 317 36 10
  • Calle Colón, 1 - 46004 (Valencia)

PRESS PACK

Last update
February 2020

Download PDF

Back to toparrow_drop_up